SEC Filing Summary: Bellevue Life Sciences Acquisition Corp. (BLAC)
Business Context and Reporting Period
This Form 8-K was filed on July 16, 2024, reporting events occurring on July 11 and July 12, 2024. The registrant, Bellevue Life Sciences Acquisition Corp. (BLAC), is a Special Purpose Acquisition Company (SPAC) incorporated in Delaware. The filing details the issuance of a promissory note to its sponsor and a subsequent deposit into its trust account to extend the deadline for consummating an initial business combination.
Key Financial Metrics
- Debt Obligation: Issued an unsecured, non-interest-bearing promissory note with a principal amount of $300,000 to Bellevue Global Life Sciences Investors, LLC (BGLSI).
- Liquidity/Trust Account: Deposited $50,000 into the trust account on July 12, 2024.
- Revenue, Profit, and Margins: The filing text does not provide a clear value for revenue, profit, cash flow, or operating margins.
Material Changes and Agreements
The primary material change is the creation of a direct financial obligation via the $300,000 promissory note. Key terms include:
- Maturity Date: The earlier of December 31, 2024, or the date of an initial business combination.
- Forgiveness Clause: If no business combination is consummated by the deadline, BGLSI agrees to forgive the principal balance, except for any funds remaining outside the trust account.
- Default Events: Failure to pay within five business days of maturity or the commencement of bankruptcy proceedings.
Outlook, Risks, and Management Commentary
The $50,000 deposit into the trust account indicates an active effort to extend the timeline for completing a business combination. The filing does not contain specific forward-looking guidance, management commentary on future performance, or a detailed discussion of risks beyond the standard default provisions of the note. The company remains an emerging growth company.
Investor Verification Checklist
- Verify the total balance currently held in the trust account following the $50,000 deposit.
- Confirm the exact extended deadline for consummating a business combination.
- Review the full text of the Promissory Note (Exhibit 10.1) for any additional covenants or conditions not summarized in the 8-K.
- Monitor for any subsequent filings regarding the status of the business combination search or further extensions.